48 MMP 14-48: Alessandro Fatatis, MD, Ph. D. Kerberos Biopharmaceuticals, Inc.
Kimon C. Hatza, Partner Millcrest Law, LLP Charles Huntington, Pennsylvania Bio PR Chair Alessandro Fatatis, MD, Ph. D. Founder Kerberos Biopharmaceuticals, Inc. The focus of Dr. Fatatis’s research is the identification of novel biomarkers and therapeutic targets for the management … Continue reading →